Wooters, T. ., Smith, A. ., Pivavarchyk, M. ., Siripurapu, K. ., McIntosh, J. ., Zhang, Z. ., … Dwoskin, L. . (2011). bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. British Journal of Pharmacology, 163(2), 346-57. https://doi.org/10.1111/j.1476-5381.2011.01220.x

Smith, A. ., Pivavarchyk, M. ., Wooters, T. ., Zhang, Z. ., Zheng, G. ., McIntosh, J. ., … Dwoskin, L. . (2010). Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. Biochemical Pharmacology, 80(3), 402-9. https://doi.org/10.1016/j.bcp.2010.03.018 (Original work published 2010)

Dwoskin, L. ., Smith, A. ., Wooters, T. ., Zhang, Z. ., Crooks, P. ., & Bardo, M. . (2009). Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochemical Pharmacology, 78(7), 732-43. https://doi.org/10.1016/j.bcp.2009.06.002 (Original work published 2009)

Beckmann, J. ., Meyer, A. ., Pivavarchyk, M. ., Horton, D. ., Zheng, G. ., Smith, A. ., … Dwoskin, L. . (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4

Ganguli, A. ., Ornob, A. ., Spegazzini, N. ., Liu, Y. ., Damhorst, G. ., Ghonge, T. ., … Bashir, R. . (2018). Pixelated spatial gene expression analysis from tissue. Nature Communications, 9(1), 202. https://doi.org/10.1038/s41467-017-02623-9 (Original work published 2018)

Heathcote, L. ., Williams, S. ., Smith, A. ., Sieberg, C. ., & Simons, L. . (2018). Parent Attributions of Ambiguous Symptoms in Their Children: A Preliminary Measure Validation in Parents of Children with Chronic Pain. Children (Basel, Switzerland), 5(6). https://doi.org/10.3390/children5060076 (Original work published 2018)